Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

GSK finance director barred from leaving China

July 18, 2013 Medical Communications, Sales and Marketing GSK, bribes, corruption, hong

GlaxoSmithKline’s finance director and British citizen Steve Nechelput has been stopped from the leaving China as the bribery case into …
News

Tissue Regenix appoints Sanofi VP

July 18, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing couldwell, tissue regenix

Medical devices firm Tissue Regenix has appointed Steven Couldwell as a non-executive director. With over 14 years of senior management …
Appointment

Marginal sales increase for Abbott

July 18, 2013 Sales and Marketing AbbVie, Abbott, Q2

Abbott’s second quarter results saw the company buffeted by currency exchange issues – primarily the yen weakening against the US …
News

J&J sees Q2 sales rise

July 17, 2013 Sales and Marketing Elan, J&J, JJ, Q2, Synthes, sales

Johnson & Johnson saw overall sales rise 8.5% year-on-year in the second quarter of 2013, with the US healthcare group …
News

Lundbeck/Otsuka Alzheimer’s drug improves cognition

July 17, 2013 Research and Development, Sales and Marketing Alzheimer's, Lundbeck, Otsuka

Lundbeck and partner Otsuka have posted positive Phase II results for their experimental Alzheimer’s drug. The latest data show statistically …
News

Eleven hospitals put on notice

July 17, 2013 Sales and Marketing Hunt, Labour, Mid Staffs, NHS, burnham, keogh

There were angry exchanges in the House of Commons yesterday as health secretary Jeremy Hunt announced that 11 hospitals in …
News

WinchPharma appoints new chief executive

July 17, 2013 Manufacturing and Production, Research and Development, Sales and Marketing lyndon nicholson, winchpharma

Healthcare products firm WinchPharma has appointed Lyndon Nicholson as its new chief executive with immediate effect.  Nicholson will replace former …
Appointment

Dementia rates declining in UK

July 17, 2013 Research and Development, Sales and Marketing Alzheimer's, UK, brain, dementia

A new study has found that the rate of dementia in Britain has decreased over the past two decades, contrary …
News

GSK exec admits bribery on live TV

July 16, 2013 Medical Communications, Sales and Marketing China, GSK, bribery, cctv

A senior member of GSK China has appeared on state television admitting the firm’s guilt in the ongoing bribery allegations. …
News

Ipsen buys Syntaxin

July 16, 2013 Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi

French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …
News

Roche ‘considers’ Alexion bid

July 16, 2013 Research and Development, Sales and Marketing Alexion, Orphan, Roche, soliris

Speculation that Roche is considering a bid for rare disease specialist Alexion Pharmaceuticals has unleashed a flurry of comment – …
News

The pharma industry in the public imagination

July 16, 2013 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Adams, image, literary, pharma

Popular culture in both films and literature depict pharma and scientists as part of a nefarious industry, hell bent on …
Feature

NICE rejects Pfizer blood cancer drug

July 16, 2013 Sales and Marketing BMS, CML, NICE, Pfizer, bosulif

NICE is not recommending Pfizer’s blood cancer drug Bosulif due to uncertainties over its cost effectiveness and survival benefit. In …
News

Aesica appoints two new business development managers

July 16, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Aesica, ross, thomas

Contract development and manufacturing organisation Aesica has appointed Sven Thomas and David Ross as business development managers. Under the new …
Appointment

Lilly revisits Alzheimer’s drug

July 15, 2013 Research and Development, Sales and Marketing Alzheimer's, lilly, solanezumab

Eli Lilly & Co is to run yet another trial of its Alzheimer’s drug solanezumab, which failed twice in Phase …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026